EDBT 2026 Demo / reviewers in the wild / expert
Jejo Koola
dblp:186/4296 · also Jejo D. Koola
· DBLP profile ↗
15ranked-venue papers
9as first author
6since 2021 · last 2025
0000-0001-5171-8475ORCID · corroborated
Domains — the database's venue-derived domains; a paper can count in several
Applied, interdisciplinary, general and emerging computing · 15 · 9 first-author · 6 since 2021
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2025 | A machine learning framework to adjust for learning effects in medical device safety evaluationabstractOBJECTIVES: Traditional methods for medical device post-market surveillance often fail to accurately account for operator learning effects, leading to biased assessments of device safety. These methods struggle with non-linearity, complex learning curves, and time-varying covariates, such as physician experience. To address these limitations, we sought to develop a machine learning (ML) framework to detect and adjust for operator learning effects. MATERIALS AND METHODS: A gradient-boosted decision tree ML method was used to analyze synthetic datasets that replicate the complexity of clinical scenarios involving high-risk medical devices. We designed this process to detect learning effects using a risk-adjusted cumulative sum method, quantify the excess adverse event rate attributable to operator inexperience, and adjust for these alongside patient factors in evaluating device safety signals. To maintain integrity, we employed blinding between data generation and analysis teams. Synthetic data used underlying distributions and patient feature correlations based on clinical data from the Department of Veterans Affairs between 2005 and 2012. We generated 2494 synthetic datasets with widely varying characteristics including number of patient features, operators and institutions, and the operator learning form. Each dataset contained a hypothetical study device, Device B, and a reference device, Device A. We evaluated accuracy in identifying learning effects and identifying and estimating the strength of the device safety signal. Our approach also evaluated different clinically relevant thresholds for safety signal detection. RESULTS: Our framework accurately identified the presence or absence of learning effects in 93.6% of datasets and correctly determined device safety signals in 93.4% of cases. The estimated device odds ratios' 95% confidence intervals were accurately aligned with the specified ratios in 94.7% of datasets. In contrast, a comparative model excluding operator learning effects significantly underperformed in detecting device signals and in accuracy. Notably, our framework achieved 100% specificity for clinically relevant safety signal thresholds, although sensitivity varied with the threshold applied. DISCUSSION: A machine learning framework, tailored for the complexities of post-market device evaluation, may provide superior performance compared to standard parametric techniques when operator learning is present. CONCLUSION: Demonstrating the capacity of ML to overcome complex evaluative challenges, our framework addresses the limitations of traditional statistical methods in current post-market surveillance processes. By offering a reliable means to detect and adjust for learning effects, it may significantly improve medical device safety evaluation. Jejo Koola, Karthik Ramesh, Jialin Mao, Minyoung Ahn, Sharon E. Davis, Usha Govindarajulu, Amy Perkins, Dax M. Westerman, Henry Ssemaganda, Theodore Speroff, Lucila Ohno-Machado, Craig Ramsay, Art Sedrakyan, Frederic S. Resnic, Michael E. Matheny |
J. Am. Medical Informatics Assoc. | 1 |
| 2023 | Blockchain-enabled immutable, distributed, and highly available clinical research activity logging system for federated COVID-19 data analysis from multiple institutionsabstractOBJECTIVE: We aimed to develop a distributed, immutable, and highly available cross-cloud blockchain system to facilitate federated data analysis activities among multiple institutions. MATERIALS AND METHODS: We preprocessed 9166 COVID-19 Structured Query Language (SQL) code, summary statistics, and user activity logs, from the GitHub repository of the Reliable Response Data Discovery for COVID-19 (R2D2) Consortium. The repository collected local summary statistics from participating institutions and aggregated the global result to a COVID-19-related clinical query, previously posted by clinicians on a website. We developed both on-chain and off-chain components to store/query these activity logs and their associated queries/results on a blockchain for immutability, transparency, and high availability of research communication. We measured run-time efficiency of contract deployment, network transactions, and confirmed the accuracy of recorded logs compared to a centralized baseline solution. RESULTS: The smart contract deployment took 4.5 s on an average. The time to record an activity log on blockchain was slightly over 2 s, versus 5-9 s for baseline. For querying, each query took on an average less than 0.4 s on blockchain, versus around 2.1 s for baseline. DISCUSSION: The low deployment, recording, and querying times confirm the feasibility of our cross-cloud, blockchain-based federated data analysis system. We have yet to evaluate the system on a larger network with multiple nodes per cloud, to consider how to accommodate a surge in activities, and to investigate methods to lower querying time as the blockchain grows. CONCLUSION: Blockchain technology can be used to support federated data analysis among multiple institutions. Tsung-Ting Kuo, Anh Pham, Maxim E. Edelson, Jihoon Kim 0001, Yash Gupta, Lucila Ohno-Machado, David M. Anderson, Chandrasekar Balacha, Tyler Bath, Sally L. Baxter, Andrea Becker-Pennrich, Douglas S. Bell, Elmer V. Bernstam, Ngan Chau, Michele E. Day, Jason N. Doctor, Scott L. DuVall, Robert El-Kareh, Renato Florian, Robert W. Follett, Benjamin P. Geisler, Alessandro Ghigi, Assaf Gottlieb, Christian Hinske, Zhaoxian Hu, Diana Ir, Xiaoqian Jiang, Katherine K. Kim, Tara K. Knight, Jejo Koola, Ulrich Mansmann, Michael E. Matheny, Daniella Meeker, Zongyang Mou, Larissa Neumann, Nghia H. Nguyen, Nicholas R. Anderson 0001, Eunice Park, Paulina Paul, Mark J. Pletcher, Kai W. Post, Clemens Rieder, Clemens Scherer, Lisa M. Schilling, Andrey Soares, Spencer L. SooHoo, Ekin Soysal, Steven Covington, Brian Tep, Brian Toy, Baocheng Wang, Zhen R. Wu, Hua Xu 0001, Yong K. Choi, Kai Zheng 0002, Yujia Zhou 0003, Rachel A Zucker |
J. Am. Medical Informatics Assoc. | 31 |
| 2022 | A Framework for Generating Synthetic Clinical Datasets with Learning Effects to Support Methods Development and Validation
Sharon E. Davis, Henry Ssemaganda, Jejo Koola, Jialin Mao, Dax M. Westerman, Theodore Speroff, Usha Govindarajulu, Craig Ramsay, Lucila Ohno-Machado, Frederic S. Resnic, Michael E. Matheny |
AMIA | 3 |
| 2022 | Identifying Diagnostic Opportunities Using Clinical Trajectories
Jejo Koola, David Laub, Shamim Nemati, Robert El-Kareh |
AMIA | 1 |
| 2022 | A Framework for Detecting Medical Device Safety Signals Confounded by Learning Effects Using Machine Learning
Jejo Koola, Jialin Mao, Sharon E. Davis, Henry Ssemaganda, Dax M. Westerman, Lucila Ohno-Machado, Frederic S. Resnic, Michael E. Matheny |
AMIA | 1 |
| 2022 | Disentangling and Characterizing Device Safety Signals and Learning Effects
Henry Ssemaganda, Frederic S. Resnic, Sharon E. Davis, Usha Govindarajulu, Jejo Koola, Jialin Mao, Dax M. Westerman, Theodore Speroff, Craig Ramsay, Art Sedrakyan, Lucila Ohno-Machado, Michael E. Matheny |
AMIA | 5 |
| 2020 | Diagnosing Chemotherapy-Related Cognitive Impairment Using Digital Phenotyping
Marehan Waly, Teresa Helsten, Nhan Vuong, Amanda Gooding, William Frederick, Alex D. Leow, Jejo Koola |
AMIA | 7 |
| 2020 | Electronic Health Record Phenotyping of Patients with Drug-Induced Renal Injury
Zaid K. Yousif, Linda Awdishu, Michael A. Hogarth, Jejo Koola |
AMIA | 4 |
| 2019 | Identifying Early Hepatic Encephalopathy Through Digital Phenotyping
Jejo Koola, Veeral Ajmera, Job Godino, Lauren L'Heureux, Amanda Gooding, Marc Norman, Faraz Hussain 0002, Alex D. Leow |
AMIA | 1 |
| 2018 | Development of an automated phenotyping algorithm for hepatorenal syndrome
Jejo Koola, Sharon E. Davis, Omar Al-Nimri, Sharidan K. Parr, Daniel Fabbri, Bradley A. Malin, Samuel B. Ho, Michael E. Matheny |
J. Biomed. Informatics | 1 |
| 2017 | Machine Learning Models to Predict Readmission for Patients with Cirrhosis
Jejo Koola, Aize Cao, Guanhua Chen 0002, Amy Perkins, Samuel B. Ho, Sharon E. Davis, Michael E. Matheny |
AMIA | 1 |
| 2016 | Workflow-guided development of a clinical decision support tool for patients with advanced liver disease
Samuel B. Ho, Julie Ducom, Jennifer H. Garvin, Jejo Koola, Russ Beebe, Jason Slagle, Dax M. Westerman, Carrie Reale, Matthew B. Weinger, Erik Groessl, Michael E. Matheny |
AMIA | 5 |
| 2016 | An Electronic Health Record Phenotyping Algorithm for Identifying Patients with Hepatorenal Syndrome
Jejo Koola, Samuel B. Ho, Michael E. Matheny |
AMIA | 1 |
| 2015 | A Novel Visualization for Rapid Summarization of Patient History: Application to Cirrhosis
Jejo Koola, Samuel B. Ho, Michael E. Matheny |
AMIA | 1 |
| 2014 | Development of a Cirrhosis-Associated Symptom/Finding Detection Tool
Jejo Koola, Robert M. Cronin, Ruth M. Reeves, Jason N. Denton, Samuel B. Ho, Michael E. Matheny |
AMIA | 1 |